
New formulation associated with delayed time to impending relapse, as well as improvements on measures of symptom severity and treatment response.

New formulation associated with delayed time to impending relapse, as well as improvements on measures of symptom severity and treatment response.

New validated assessment tools allow clinicians to better assess the level of real-life functioning in patients with schizophrenia.